CA2120336A1 - Detecting digeorge syndrome mutations - Google Patents

Detecting digeorge syndrome mutations

Info

Publication number
CA2120336A1
CA2120336A1 CA002120336A CA2120336A CA2120336A1 CA 2120336 A1 CA2120336 A1 CA 2120336A1 CA 002120336 A CA002120336 A CA 002120336A CA 2120336 A CA2120336 A CA 2120336A CA 2120336 A1 CA2120336 A1 CA 2120336A1
Authority
CA
Canada
Prior art keywords
digeorge syndrome
syndrome
digeorge
detecting
human patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002120336A
Other languages
French (fr)
Other versions
CA2120336C (en
Inventor
Beverly S. Emanuel
Marcia L. Budarf
Deborah A. Driscoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
University of Pennsylvania Penn
Original Assignee
Beverly S. Emanuel
Marcia L. Budarf
Deborah A. Driscoll
The Trustees Of The University Of Pennsylvania
The Children's Hospital Of Philadelphia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beverly S. Emanuel, Marcia L. Budarf, Deborah A. Driscoll, The Trustees Of The University Of Pennsylvania, The Children's Hospital Of Philadelphia filed Critical Beverly S. Emanuel
Publication of CA2120336A1 publication Critical patent/CA2120336A1/en
Application granted granted Critical
Publication of CA2120336C publication Critical patent/CA2120336C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

There is provided by this invention methods of detecting genetic deletions and mutations associated with at least one condition selected from the group consisting of DiGeorge syndrome, Velocardiofacial syndrome, CHARGE association, conotruncal cardiac defect, and cleft palate in a human patient comprising the steps of providing a DNA containing test sample from said human patient; identifying whether there are less than two functional copies of the DiGeorge syndrome critical region loci, whereby said identification of less than two copies of the DiGeorge syndrome critical region loci is indicative of a likelihood that said person has at least one of DiGeorge syndrome, Velocardiofacial syndrome, CHARGE association, conotruncal cardiac defect, and cleft palate. Probes and primers useful in the invention are also provided as are diagnostic kits.
CA002120336A 1991-10-04 1992-09-02 Detecting digeorge syndrome mutations Expired - Lifetime CA2120336C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US77075891A 1991-10-04 1991-10-04
US770,758 1991-10-04
US91153492A 1992-07-10 1992-07-10
US911,534 1992-07-10
PCT/US1992/007536 WO1993007293A1 (en) 1991-10-04 1992-09-02 Detecting digeorge syndrome mutations

Publications (2)

Publication Number Publication Date
CA2120336A1 true CA2120336A1 (en) 1993-04-15
CA2120336C CA2120336C (en) 2007-04-24

Family

ID=27118352

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002120336A Expired - Lifetime CA2120336C (en) 1991-10-04 1992-09-02 Detecting digeorge syndrome mutations

Country Status (8)

Country Link
US (1) US5576178A (en)
EP (1) EP0672172B1 (en)
JP (1) JPH07501691A (en)
AT (1) ATE197964T1 (en)
AU (1) AU675774B2 (en)
CA (1) CA2120336C (en)
DE (1) DE69231595T2 (en)
WO (1) WO1993007293A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303294B1 (en) * 1991-10-04 2001-10-16 The Children's Hospital Of Philadelphia Methods of detecting genetic deletions and mutations associated with Digeorge syndrome, Velocardiofacial syndrome, CHARGE association, conotruncal cardiac defect, and cleft palate and probes useful therefore
US6022689A (en) * 1995-04-07 2000-02-08 University Of New Mexico Situ hybridization slide processes
WO1997011088A1 (en) * 1995-09-20 1997-03-27 The Children's Hospital Of Philadelphia Novel genes mapping in the digeorge and velocardiofacial syndrome minimal critical region
WO1997013869A1 (en) * 1995-10-10 1997-04-17 The Regents Of The University Of California Detection of allele-specific mutations by allele-specific in situ reverse transcriptase polymerase chain reaction
US8043835B1 (en) 1996-03-26 2011-10-25 Oncomedx, Inc. Methods for detecting and monitoring cancer using extracellular RNA
ES2347854T5 (en) * 1996-03-26 2014-07-24 Michael S. Kopreski Method that allows the use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate a cancer
US7785842B2 (en) * 1996-03-26 2010-08-31 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US6759217B2 (en) * 1996-03-26 2004-07-06 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US6607898B1 (en) * 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US6794135B1 (en) * 1996-03-26 2004-09-21 Oncomedx, Inc. Method for detection of 5T4 RNA in plasma or serum
US8440396B2 (en) * 1997-03-14 2013-05-14 Oncomedx, Inc. Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US20070009934A1 (en) * 1997-03-14 2007-01-11 Kopreski Michael S Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
US7767422B2 (en) * 1998-09-22 2010-08-03 Oncomedx, Inc. Detection of 5T4 RNA in plasma and serum
US20060204989A1 (en) * 1998-09-22 2006-09-14 Kopreski Michael S Comparative analysis of extracellular RNA species
US8163524B2 (en) * 1998-09-22 2012-04-24 Oncomedx, Inc. Comparative analysis of extracellular RNA species
US20090233276A1 (en) * 1998-09-22 2009-09-17 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
DE60144027D1 (en) * 2000-08-28 2011-03-24 Oncomedx Inc 5T4 RNA IN PLASMA AND SERUM AS A MARKER FOR NEOPLASTIC ILLNESSES
DK1421215T3 (en) * 2001-07-25 2011-06-27 Oncomedx Inc Methods for evaluating pathological conditions using extracellular RNA
US20030104454A1 (en) * 2001-11-05 2003-06-05 Kopreski Michael S. Method for detection of DNA methyltransferase RNA in plasma and serum
US20100159464A1 (en) * 2001-11-05 2010-06-24 Oncomedx, Inc. Method for Detection of DNA Methyltransferase RNA in Plasma and Serum
CA2502549C (en) * 2004-04-23 2016-02-16 Becton, Dickinson And Company Use of an extraction control in a method of extracting nucleic acids
US20090104620A1 (en) * 2007-07-03 2009-04-23 Axial Biotech, Inc. Simplified Method of Determining Predisposition to Scoliosis
US20090035772A1 (en) * 2007-07-03 2009-02-05 Axial Biotech, Inc. Genetic Markers Associated With Scoliosis And Uses Thereof
US20090035769A1 (en) * 2007-12-31 2009-02-05 Nelson Lesa M Genetic Markers Associated with Scoliosis and Uses Thereof
US20090136942A1 (en) * 2007-09-18 2009-05-28 Oncomedx, Inc. Analysis of Extracellular RNA
ES2780775A1 (en) 2019-02-25 2020-08-26 Servei De Salut De Les Illes Balears - Ibsalut METHOD TO DETECT DUPLICATIONS AND/OR DELETIONS IN THE 22q11.2 CHROMOSOME REGION (Machine-translation by Google Translate, not legally binding)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences

Also Published As

Publication number Publication date
WO1993007293A1 (en) 1993-04-15
AU2651492A (en) 1993-05-03
EP0672172A1 (en) 1995-09-20
AU675774B2 (en) 1997-02-20
DE69231595T2 (en) 2001-05-31
DE69231595D1 (en) 2001-01-11
ATE197964T1 (en) 2000-12-15
US5576178A (en) 1996-11-19
EP0672172A4 (en) 1996-08-21
EP0672172B1 (en) 2000-12-06
JPH07501691A (en) 1995-02-23
CA2120336C (en) 2007-04-24

Similar Documents

Publication Publication Date Title
CA2120336A1 (en) Detecting digeorge syndrome mutations
Fisher et al. A quantitative-trait locus on chromosome 6p influences different aspects of developmental dyslexia
Gilchrist et al. Clinical and genetic investigation in autosomal dominant limb‐girdle muscular dystrophy
WO1998053076A3 (en) Compounds for diagnosis of tuberculosis and methods for their use
WO2004020968A3 (en) Mutations in nod2 are associated with fibrostenosing disease in patients with crohn’s disease
HK1057217A1 (en) Method of diagnosing alzheimer' s disease on the basis of a gene transcript pattern
Varma et al. Diversity of DNA fingerprints in Cryptococcus neoformans
WO1998016645A3 (en) Compounds and methods for diagnosis of tuberculosis
DANS et al. Inappropriate use of the cerebrospinal fluid Venereal Disease Research Laboratory (VDRL) test to exclude neurosyphilis
Keats et al. Tightly linked flanking microsatellite markers for the Usher syndrome type I locus on the short arm of chromosome 11.
EP1612280A3 (en) Diagnosis and treatment of Williams syndrome
Johns et al. Pitfalls in the molecular genetic diagnosis of Leber hereditary optic neuropathy (LHON).
WO1992019770A3 (en) Process for the in vitro diagnosis of chromosomal anomalies correlated with cmt1a disease
CA2155387A1 (en) Species-Specific Detection of Mycobacterium Kansasii
Major et al. DYT1 mutation in primary torsion dystonia in a Serbian population
EP1132483A3 (en) Method for diagnosing schizophrenia using objective indices
Van Demark et al. Prediction of Velopharyngeal Competancy
Hecht et al. Direct molecular diagnosis of myotonic dystrophy
McCormack et al. Factor Structure of the Million Clinical Multiaxial Inventory (MCMI) With an Offender Sample
Kalsi et al. Linkage analysis of manic depression (bipolar affective disorder) in Icelandic and British kindreds using markers on the short arm of chromosome 18
AU2808500A (en) Diagnostic and screening method
Edwards‐Moulds et al. Studies of the Diego blood group among Mexican‐Americans
WO2004018711A3 (en) Diagnostic test
Uldall et al. Kits for the diagnosis of infectious mononucleosis compared with the Paul-Bunnell test
Lastovica et al. Additional data on clinical isolates of Campylobacter mucosalis

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry